The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm.sup.3. Such food products, when administered to affected subjects, can positively impact (i) nutritional status; (ii) quality of life; (iii) disease course; (v) the demand for assistance from a care giver; (vi) subject compliance with a nutritional plan using the food product, and (vii) ease of monitoring compliance by the caregiver for verification.

A composition comprises live cells of Bifidobacterium longum NCIMB 41676 and a plurality of B vitamins selected from B1, B2, B3, B5, B6, B7, B9 and B12.

A composition comprises live cells of Bifidobacterium longum NCIMB 41676 and a plurality of B vitamins selected from B1, B2, B3, B5, B6, B7, B9 and B12.

Compositions for energy supplements are provided containing L-tryptophan in an amount of 15-28%, CoQ10 in an amount of 7-15%, pyrroloquinaline quinone in an amount of 0.4-5%, niacinamide in an amount of 2-9%, niacin in an amount of 0.4-5%, magnesium in an amount of 4-20%, acetyl-L-carnitine in an amount of 10-28%, alpha liolic acid in an amount of 10-30%, N-acetyl cysteine in an amount of 4-15%, and resveratrol an amount of 3-14% administered with a daily supplement of D-Ribose in an amount of 500 mg to 15,000 mg. The compositions providing an unexpected increase in mitochondrial biogenesis, activity, and preservation and therefore increased energy availability.

Compositions for energy supplements are provided containing L-tryptophan in an amount of 15-28%, CoQ10 in an amount of 7-15%, pyrroloquinaline quinone in an amount of 0.4-5%, niacinamide in an amount of 2-9%, niacin in an amount of 0.4-5%, magnesium in an amount of 4-20%, acetyl-L-carnitine in an amount of 10-28%, alpha liolic acid in an amount of 10-30%, N-acetyl cysteine in an amount of 4-15%, and resveratrol an amount of 3-14% administered with a daily supplement of D-Ribose in an amount of 500 mg to 15,000 mg. The compositions providing an unexpected increase in mitochondrial biogenesis, activity, and preservation and therefore increased energy availability.

Provided is a method for producing a rumen-bypassing preparation which is produced at a low cost and simultaneously achieves the objects of protecting an active ingredient from release and decomposition in the first stomach and increasing release behavior in a target internal organ. A granular agent obtained thereby is also described. The method includes a step of applying vibration to a die head containing a melt of a coating agent for the rumen-bypassing preparation and a nutrient to bypass a rumen and having at least one injection port or to the melt, thereby injecting the melt from the injection port.

Provided is a method for producing a rumen-bypassing preparation which is produced at a low cost and simultaneously achieves the objects of protecting an active ingredient from release and decomposition in the first stomach and increasing release behavior in a target internal organ. A granular agent obtained thereby is also described. The method includes a step of applying vibration to a die head containing a melt of a coating agent for the rumen-bypassing preparation and a nutrient to bypass a rumen and having at least one injection port or to the melt, thereby injecting the melt from the injection port.

The present invention relates to a composition comprising at least one fucosylated oligosaccharide, for use in preventing allergies and/or treating allergies and/or reducing the occurrence or the risk of allergies in an infant or a young child born from a mother deficient in at least one fucosylated oligosaccharide(s) or fed with a mother's milk deficient in at least one fucosylated oligosaccharide(s). The use of said composition in infant formula, milk fortifier or children's food is foreseen.

The present invention relates to a composition comprising at least one fucosylated oligosaccharide, for use in preventing allergies and/or treating allergies and/or reducing the occurrence or the risk of allergies in an infant or a young child born from a mother deficient in at least one fucosylated oligosaccharide(s) or fed with a mother's milk deficient in at least one fucosylated oligosaccharide(s). The use of said composition in infant formula, milk fortifier or children's food is foreseen.

This invention relates to the use of the combination of 25-hydroxyvitamin D3 (25-OH D3) and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.